The US market is witnessing increasing emphasis on selecting anti-arrhythmic therapies according to patient-specific clinical characteristics. Treatment decisions can consider structural heart disease, heart failure status, previous cardiovascular events, renal function, and potential interactions between medicines.
The Anti-Arrhythmic Drug Market is witnessing steady expansion as the global...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek